Depression, antidepressants, and insulin resistance: which link?

Giuseppe Fanelli; Alessandro Serretti

doi:10.1016/j.euroneuro.2022.04.011

Depression, antidepressants, and insulin resistance: which link?

Eur Neuropsychopharmacol. 2022 Jul:60:4-6. doi: 10.1016/j.euroneuro.2022.04.011. Epub 2022 May 9.

Authors

Giuseppe Fanelli¹, Alessandro Serretti²

Affiliations

¹ Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
² Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. Electronic address: alessandro.serretti@unibo.it.

PMID: 35550451
DOI: 10.1016/j.euroneuro.2022.04.011

No abstract available

Keywords: Antidepressants; Diabetes mellitus; Insulin; Major depressive disorder; Metabolic syndrome; Obesity; Peroxisome proliferator-activated receptor γ.

MeSH terms

Antidepressive Agents / pharmacology
Antidepressive Agents / therapeutic use
Depression / drug therapy
Diabetes Mellitus, Type 2*
Humans
Insulin
Insulin Resistance*
Obesity

Substances

Antidepressive Agents
Insulin